易感性血管征是接受机械血栓切除术治疗的中风患者长期结果的预测因子。
Susceptibility vessel sign, a predictor of long-term outcome in patients with stroke treated with mechanical thrombectomy.
发表日期:2023 Nov 02
作者:
Morin Beyeler, Erich Rea, Loris Weber, Nebiyat Filate Belachew, Enrique Barvulsky Aleman, Moritz Kielkopf, Christoph C Kurmann, Lorenz Grunder, Eike Immo I Piechowiak, Thomas R Meinel, Mirjam R Heldner, David Seiffge, Sara Pilgram-Pastor, Tomas Dobrocky, Thomas Pabst, Martin D Berger, Simon Jung, Marcel Arnold, Jan Gralla, Urs Fischer, Johannes Kaesmacher, Adnan Mujanovic
来源:
Journal of NeuroInterventional Surgery
摘要:
接受机械血栓切除术 (MT) 治疗的患者缺乏磁敏感血管征 (SVS) 与 3 个月后不良的放射学和临床结果相关。癌症等潜在疾病被认为会影响 SVS 状态,并可能影响长期结果。我们的目的是评估 SVS 状态作为 MT 治疗患者长期结局的独立预测因子。SVS 状态是在 2010 年至 2018 年间在综合性卒中中心连续接受 MT 治疗的患者中回顾性确定的。长期死亡率和不良预后的预测因子分别使用多变量 Cox 和逻辑回归确定长达 8 年的功能结果(改良 Rankin 量表 (mRS) ≥3)。在纳入的 558 名患者中,13% (n=71) 不存在 SVS,87% (n=71) 存在 SVS。 n=487) 的基线成像。没有 SVS 的患者在中风时更有可能患有活动性癌症 (P=0.003) 和糖尿病 (P<0.001)。中位长期随访时间为 1058 天(IQR 533-1671 天)。在对活动性癌症和糖尿病等进行调整后,缺乏 SVS 与长期死亡率(调整后 HR (aHR) 2.11,95%CI 1.35 至 3.29)和长期功能结果不佳(调整后 OR( aOR) 2.90, 95%CI 1.29 至 6.55)。未接受 SVS 的 MT 治疗患者的长期死亡率较高,长期功能结果较差。看来这种关联不能仅用合并症来解释,需要进一步研究。© 作者(或其雇主)2023。禁止商业重复使用。请参阅权利和权限。英国医学杂志出版。
The absence of the susceptibility vessel sign (SVS) in patients treated with mechanical thrombectomy (MT) is associated with poor radiological and clinical outcomes after 3 months. Underlying conditions, such as cancer, are assumed to influence SVS status and could potentially impact the long-term outcome. We aimed to assess SVS status as an independent predictor of long-term outcomes in MT-treated patients.SVS status was retrospectively determined in consecutive MT-treated patients at a comprehensive stroke center between 2010 and 2018. Predictors of long-term mortality and poor functional outcome (modified Rankin Scale (mRS) ≥3) up to 8 years were identified using multivariable Cox and logistic regression, respectively.Of the 558 patients included, SVS was absent in 13% (n=71) and present in 87% (n=487) on baseline imaging. Patients without SVS were more likely to have active cancer (P=0.003) and diabetes mellitus (P<0.001) at the time of stroke. The median long-term follow-up time was 1058 days (IQR 533-1671 days). After adjustment for active cancer and diabetes mellitus, among others, the absence of SVS was associated with long-term mortality (adjusted HR (aHR) 2.11, 95% CI 1.35 to 3.29) and poor functional outcome in the long term (adjusted OR (aOR) 2.90, 95% CI 1.29 to 6.55).MT-treated patients without SVS have higher long-term mortality rates and poorer long-term functional outcome. It appears that this association cannot be explained by comorbidities alone, and further studies are warranted.© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.